Tianli Yuan

No.1630, Dongfang Road
Dongfang, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Author Correction: Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.

Author Correction: Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.

Journal: Nature cancer

Published: August 26, 2026

KRASG12/13 mutation modulates CRC outcomes via disrupting positive feedback between macrophage and CD4+ T cell.

KRASG12/13 mutation modulates CRC outcomes via disrupting positive feedback between macrophage and CD4+ T cell.

Journal: iScience

Published: July 23, 2025

Metagenomic Microbial Signatures for Noninvasive Detection of Pancreatic Cancer.

Metagenomic Microbial Signatures for Noninvasive Detection of Pancreatic Cancer.

Journal: Biomedicines

Published: March 10, 2025

Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.

Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.

Journal: Nature cancer

Published: January 10, 2025

Development of a novel angiogenesis-associated gene model for prognosis prediction in colorectal cancer.

Development of a novel angiogenesis-associated gene model for prognosis prediction in colorectal cancer.

Journal: BMC cancer

Published: July 15, 2024

Atg16l2 augments Nlrc4 inflammasome activation by facilitating NAIPs-NLRC4 association.

Atg16l2 augments Nlrc4 inflammasome activation by facilitating NAIPs-NLRC4 association.

Journal: European journal of immunology

Published: February 14, 2024

Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions.

Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions.

Journal: Clinical epigenetics

Published: November 04, 2022

ATG16L2 inhibits NLRP3 inflammasome activation through promoting ATG5-12-16L1 complex assembly and autophagy.

ATG16L2 inhibits NLRP3 inflammasome activation through promoting ATG5-12-16L1 complex assembly and autophagy.

Journal: European journal of immunology

Published: December 11, 2021

Pretreatment with metformin prevents microcystin-LR-induced tau hyperphosphorylation via mTOR-dependent PP2A and GSK-3β activation.

Pretreatment with metformin prevents microcystin-LR-induced tau hyperphosphorylation via mTOR-dependent PP2A and GSK-3β activation.

Journal: Environmental toxicology

Published: November 10, 2020

Microcystin-LR Induces NLRP3 Inflammasome Activation via FOXO1 Phosphorylation, Resulting in Interleukin-1β Secretion and Pyroptosis in Hepatocytes.

Microcystin-LR Induces NLRP3 Inflammasome Activation via FOXO1 Phosphorylation, Resulting in Interleukin-1β Secretion and Pyroptosis in Hepatocytes.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: October 20, 2020

Reduced methylation of PP2Ac promotes ethanol-induced lipid accumulation through FOXO1 phosphorylation in vitro and in vivo.

Reduced methylation of PP2Ac promotes ethanol-induced lipid accumulation through FOXO1 phosphorylation in vitro and in vivo.

Journal: Toxicology letters

Published: February 02, 2020

Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.

Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: December 12, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026